27. March 2020 | 14:20 CET
Drägerwerk or Micro-X - how do investors benefit from the Corona Pandemic?
The current Corona Pandemic is challenging people around the globe. Doctors and medical staff are under particular strain. For some time now, it has become clear that there is a lack of material and equipment to withstand a large onslaught of infected Covid-19 patients. In order to slow down the spread of the virus, the population is urged to avoid social contacts. Manufacturers of equipment and materials for the medical sector are now being flooded with orders to compensate for the shortage, and investors have the opportunity to make a financial investment.
time to read: 1 minutes by Mario Hose
Author
Mario Hose
Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.
Federal government fills supply gap
The ventilators and medical protective equipment of Drägerwerk AG & Co. KGaA are in great demand. Two weeks ago, the company received a major order from the German government. According to the announcement, the delivery of 10,000 ventilators and protective equipment for medical personnel was agreed. The delivery will cover the next 12 months. This order is directly related to the spread of the corona virus and will be used to supply the healthcare system.
Product to combat shortages
In addition to ventilators, X-ray equipment is also needed to monitor the course of the disease in the patient's lungs. In recent years, the Australian company Micro-X Limited has developed a mobile X-ray unit that is now going into series production. The device is called the Carestream DRX Revolution Nano. The advantage is that the device can be moved, which increases the treatment comfort of the patients.
Based on the demand for the devices, the company will adapt its growth strategy and immediately initiate operational measures originally planned for a later date, Micro-X recently announced. As hospitals are now the focus of events and gaps in medical care are becoming apparent, more money is expected to flow into healthcare now and in the future.
Sales increase significantly
While Drägerwerk is a traditional billion-dollar company, at Micro-X investors can enter a growth story that is now experiencing high demand. In the past fiscal year, the company generated sales of AUD 1.9 million and was already able to announce incoming orders of AUD 2.4 million in the first quarter of 2020.
Micro-X's market capitalisation is currently AUD 31.25 million at the closing price of AUD 0.125 on the home exchange ASX. The shares of the company are not (yet) listed in Germany but information on the security is available and trading on the ASX is possible via the following details: ISIN: AU0000MX15, WKN: A2ACCY, ASX: MX1 or via the website: micro-x.com.
